#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14114	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2033	689.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1418	1418	C	772	C	728	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14114	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2033	689.6	0	HET	.	.	.	C207T	.	207	207	C	441	441	C	817	C,T	605,163	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14114	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2033	689.6	0	HET	.	.	.	C451T	.	451	451	C	685	685	C	764	C,T	358,365	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26124	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3551	733.6	0	.	n	.	0	T695C	SNP	695	695	T	1049	1049	C	811	C	771	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26124	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3551	733.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2325	2325	C	844	C	788	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26124	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3551	733.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2399	2399	A	818	A	767	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26124	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3551	733.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2951	2951	C	745	C,T	699,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26124	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3551	733.6	0	HET	.	.	.	G888A,T	.	888	888	G	1242	1242	G	807	G,A,T	582,166,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26124	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3551	733.6	0	HET	.	.	.	A1638G	.	1638	1638	A	1992	1992	A	867	A,G	617,202	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1778	folP	855	855	100.0	folP.l15.c17.ctg.1	1533	115.2	1	SNP	p	R229S	1	.	.	685	687	AGC	938	940	AGC	175;180;180	A;G;C	165;172;169	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5676	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3415	165.7	1	SNP	p	S91F	1	.	.	271	273	TTC	569	571	TTC	205;208;207	T;T;C	192;195;194	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5676	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3415	165.7	1	SNP	p	G95N	0	.	.	283	285	GGC	581	583	GGC	205;204;201	G;G,A;C	195;193,1;190	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5676	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3415	165.7	1	SNP	p	D95G	1	.	.	283	285	GGC	581	583	GGC	205;204;201	G;G,A;C	195;193,1;190	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1550	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1303	118.3	1	SNP	p	G45D	0	.	.	133	135	GGC	499	501	GGC	200;200;200	G;G;C,T	181;181;181,1	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	842	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1076	78.0	0	.	n	.	0	A197.	DEL	197	197	A	565	565	A	226	A	211	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5590	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2876	193.7	1	SNP	p	D86N	0	.	.	256	258	GAC	542	544	GAC	201;202;201	G;A;C	188;187;193	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5590	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2876	193.7	1	SNP	p	R87I	0	.	.	259	261	CGT	545	547	CGT	201;201;202	C;G,A;T	194;190,1;189	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5590	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2876	193.7	1	SNP	p	R87W	0	.	.	259	261	CGT	545	547	CGT	201;201;202	C;G,A;T	194;190,1;189	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5590	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2876	193.7	1	SNP	p	S87R	1	.	.	259	261	CGT	545	547	CGT	201;201;202	C;G,A;T	194;190,1;189	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5590	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2876	193.7	1	SNP	p	S88P	0	.	.	262	264	TCC	548	550	TCC	202;207;208	T;C;C	191;198;200	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3956	parE	1986	1986	100.0	parE.l15.c30.ctg.1	2364	165.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1400	1402	GGC	196;194;194	G;G;C	179;177;176	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3830	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2425	157.3	1	SNP	p	A311V	0	.	.	931	933	GCC	1216	1218	GCC	210;210;211	G;C;C,A	189;194;193,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3830	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2425	157.3	1	SNP	p	I312M	1	.	.	934	936	ATG	1219	1221	ATG	211;210;210	A;T;G,C	194;194;189,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3830	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2425	157.3	1	SNP	p	V316T	1	.	.	946	948	ACC	1231	1233	ACC	201;205;204	A,G;C,T;C,G	181,1;188,1;188,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3830	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2425	157.3	1	SNP	p	T316P	0	.	.	946	948	ACC	1231	1233	ACC	201;205;204	A,G;C,T;C,G	181,1;188,1;188,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3830	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2425	157.3	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1732	1734	ACC	200;200;201	A;C,A;C	182;182,1;186	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3830	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2425	157.3	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1786	1788	GCG	203;202;203	G;C;G	190;189;191	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3830	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2425	157.3	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1786	1788	GCG	203;202;203	G;C;G	190;189;191	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3830	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2425	157.3	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1909	1911	GGT	159;157;160	G;G;T	149;146;149	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3830	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2425	157.3	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1918	1920	AGC	149;148;147	A;G;C	140;139;138	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3830	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2425	157.3	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1936	1938	CCG	127;133;135	C,G;CG,CGG;G	91,5;99,1;100	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5506	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3016	181.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1563	1565	CCG	209;208;206	C;C;G	185;192;185	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2276	porA	1146	1146	99.91	porA.l15.c17.ctg.1	1637	137.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	479	479	C	130	C	121	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2834	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1629	173.1	0	.	p	.	0	V37I	NONSYN	109	111	GTA	432	434	ATA	238;237;238	A;T;A	223;224;222	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2834	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1629	173.1	0	.	p	.	0	I45V	NONSYN	133	135	ATT	456	458	GTT	222;224;228	G;T;T	210;207;212	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2834	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1629	173.1	0	.	p	.	0	G210E	NONSYN	628	630	GGA	951	953	GAA	260;259;259	G;A;A	240;244;243	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2834	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1629	173.1	1	SNP	p	G120K	1	.	.	358	360	AAG	681	683	AAG	191;193;197	A;A;G	186;189;189	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2834	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1629	173.1	1	SNP	p	N121D	0	.	.	361	363	AAC	684	686	AAC	197;198;196	A;A;C	191;191;189	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2834	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1629	173.1	1	SNP	p	A121N	1	.	.	361	363	AAC	684	686	AAC	197;198;196	A;A;C	191;191;189	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10422	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4929	210.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1122	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1079	103.8	1	SNP	p	V57M	1	.	.	169	171	ATG	579	581	ATG	233;230;229	A;T;G	219;218;217	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
